​

Fulcrum Therapeutics Ownership | Who Owns Fulcrum Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Fulcrum Therapeutics Ownership Summary

Fulcrum Therapeutics is owned by 82.74% institutional investors, 1.87% insiders, and 15.39% retail investors. Ra capital management is the largest institutional shareholder, holding 16.39% of FULC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.43% of its assets in Fulcrum Therapeutics shares.

FULC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFulcrum Therapeutics82.74%1.87%15.39%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management10.23M16.39%$48.08M
Tcg crossover management5.25M8.41%$24.68M
Blackrock funding, inc. /de5.17M8.28%$24.30M
Blackrock4.80M7.74%$29.75M
Nantahala capital management4.78M7.66%$22.46M
Suvretta capital management3.34M5.35%$15.69M
Vanguard group3.25M5.21%$15.27M
Adage capital partners gp3.00M4.81%$14.10M
Logos global management lp1.50M2.42%$9.30M
Dimensional fund advisors lp1.42M2.27%$6.67M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mass general brigham205.36K6.20%$1.27M
Tcg crossover management5.25M2.41%$24.68M
Exome asset management283.60K1.00%$1.33M
Nantahala capital management4.78M0.96%$22.46M
Logos global management lp1.50M0.75%$9.30M
Ra capital management10.23M0.64%$48.08M
Suvretta capital management3.34M0.53%$15.69M
Matisse capital128.44K0.31%$603.69K
Shay capital301.46K0.21%$1.42M
Adar1 capital management196.25K0.18%$922.37K

Top Buyers

HolderShares% AssetsChange
Blackrock4.80M0.00%3.26M
Suvretta capital management3.34M0.53%2.16M
Adage capital partners gp3.00M0.02%1.00M
State street1.04M0.00%784.41K
Woodline partners lp1.41M0.04%739.71K

Top Sellers

HolderShares% AssetsChange
Rtw investments, lp---5.85M
Cowen and company---2.96M
Trv gp iv---2.34M
Fmr90.47K--1.63M
Bioimpact capital---1.44M

New Positions

HolderShares% AssetsChangeValue
Perceptive advisors238.00K0.03%238.00K$1.12M
Susquehanna fundamental investments213.21K0.01%213.21K$1.00M
Bridgeway capital management140.00K0.01%140.00K$658.00K
State board of administration of florida retirement system130.69K0.00%130.69K$614.26K
Lmr partners llp112.50K0.00%112.50K$528.75K

Sold Out

HolderChange
Newedge advisors-3.00
Rothschild investment-45.00
Lindbrook capital-74.00
Daiwa securities group-138.00
Signaturefd-162.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024128-15.23%51,635,187-5.98%821.07%55-29.49%4525.00%
Sep 30, 20241499.56%54,770,426-15.49%870.80%77-2.53%3529.63%
Jun 30, 20241360.74%64,812,4127.35%1041.08%799.72%27-3.57%
Mar 31, 202413531.07%60,375,967-0.73%981.02%7241.18%2827.27%
Dec 31, 202310321.18%60,818,5207.84%981.18%5145.71%22-12.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.85M3.43%-
Vanguard Total Stock Mkt Idx Inv1.85M3.43%-
iShares Russell 2000 ETF1.48M2.74%-12.81K
Fidelity Growth Compy Commingled Pl O1.35M2.16%-464.60K
Fidelity Select Biotechnology1.14M1.83%-111.80K
Fidelity Small Cap Index636.35K1.18%-11.92K
Fidelity Select Pharmaceuticals Port683.60K1.10%-
Vanguard Institutional Extnd Mkt Idx Tr583.96K1.08%-
Fidelity Growth Compy Commingled Pl S494.64K0.92%-295.57K
SPDR® S&P Pharmaceuticals ETF436.70K0.81%-

Recent Insider Transactions

DateNameRoleActivityValue
May 07, 2024Tourangeau Greg Principal Accounting OfficerSell$1.83K
Mar 08, 2024Tourangeau Greg Vice President, FinanceSell$57.22K
Mar 04, 2024Sapir Alex See RemarksBuy$492.03K
May 10, 2023Tourangeau Greg Principal Accounting OfficerSell$695.10
Jan 20, 2023RA CAPITAL MANAGEMENT, L.P.-Buy$25.00M

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2-1
2024 Q111
2023 Q3--

FULC Ownership FAQ

Who Owns Fulcrum Therapeutics?

Fulcrum Therapeutics shareholders are primarily institutional investors at 82.74%, followed by 1.87% insiders and 15.39% retail investors. The average institutional ownership in Fulcrum Therapeutics's industry, Biotech Stocks , is 68.48%, which Fulcrum Therapeutics exceeds.

Who owns the most shares of Fulcrum Therapeutics?

Fulcrum Therapeutics’s largest shareholders are Ra capital management (10.23M shares, 16.39%), Tcg crossover management (5.25M shares, 8.41%), and Blackrock funding, inc. /de (5.17M shares, 8.28%). Together, they hold 33.09% of Fulcrum Therapeutics’s total shares outstanding.

Does Blackrock own Fulcrum Therapeutics?

Yes, BlackRock owns 7.74% of Fulcrum Therapeutics, totaling 4.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.75M$. In the last quarter, BlackRock increased its holdings by 3.26M shares, a 211.35% change.

Who is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested?

Mass general brigham is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.20% of its assets in 205.36K Fulcrum Therapeutics shares, valued at 1.27M$.

Who is the top mutual fund holder of Fulcrum Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fulcrum Therapeutics shares, with 3.43% of its total shares outstanding invested in 1.85M Fulcrum Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools